About Omsavresearch
Omsavresearch is a company based in India founded in 2016. The company has 39 employees. Its Indian entity Omsav Pharma Research Private Limited reported revenue of βΉ14.58 Cr.
- Headquarters India
- Employees 39
- Website omsavresearch.com
- Legal Name Omsav Pharma Research Private Limited
- Date of Incorporation 23 Feb, 2016
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹14.58 Cr
FY 2025 · +43% YoY
- Net Profit₹21.3 Lakh
FY 2025 · 1% margin
- EBITDA₹1.99 Cr
FY 2025 · 14% margin
- Employee Count39
Associated legal entities of Omsavresearch
Omsavresearch operates through Omsav Pharma Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Omsav Pharma Research Private Limited CIN U24230MH2016PTC339817 | Active | 23 Feb 2016 | Mumbai, Maharashtra | ₹14.6 Cr | 39 | 6 | View details |
Board of directors of Omsav Pharma Research Private Limited (Omsavresearch)
Omsav Pharma Research Private Limited is the primary company behind Omsavresearch. The board of Omsav Pharma Research Private Limited currently have 6 directors; the longest-serving is Om Dutt Tyagi, appointed in 2016. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Om Dutt Tyagi DIN 01965135 | Managing Director | 23 Feb 2016 | 10 yrs 8 mo | Omsav Pharma Research Private Limited |
| Ranchodlal Keshavlal Shah DIN 03470002 | Director | 07 Apr 2016 | 10 yrs 7 mo | Omsav Pharma Research Private Limited |
| Himadri Sen DIN 03552235 | Director | 12 Dec 2016 | 9 yrs 10 mo | Omsav Pharma Research Private Limited |
| Kewal Kundanlal Handa DIN 00056826 | Director | 24 Mar 2017 | 9 yrs 7 mo | Omsav Pharma Research Private Limited |
| Tushar Srivastava Kumar DIN 02277241 | Director | 30 Sep 2022 | 4 yrs 1 mo | Omsav Pharma Research Private Limited |
| Savita Tyagi DIN 09439020 | Director | 30 Sep 2022 | 4 yrs 1 mo | Omsav Pharma Research Private Limited |
Financials of Omsavresearch
Figures of Omsav Pharma Research Private Limited, the primary company behind Omsavresearch, for FY 2025. Revenue was ₹14.58 Cr (+43% year on year). Net profit was ₹21.3 Lakh (1% margin). EBITDA was ₹1.99 Cr (14% margin). Revenue has grown at a compounded annual rate of -18% over three years and +18% over five years.
- ₹14.58 CrRevenue · FY 2025 · +43% YoY
- ₹21.3 LakhNet profit · 1% margin
- ₹1.99 CrEBITDA · 14% margin
- ₹1.22 CrPaid-up capital
- 39Employees (provident fund records)
- -18%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Omsav Pharma Research Private Limited are on its company page.
Detailed financial statements for Omsavresearch
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Omsavresearch
Omsavresearch was founded in 2016.
Omsavresearch is headquartered in India.
Omsavresearch has 39 employees.
The primary company behind Omsavresearch, Omsav Pharma Research Private Limited, reported revenue of βΉ14.58 Cr for FY 2025, up 43% year on year.
Omsavresearch operates through Omsav Pharma Research Private Limited.
The legal entities of Omsavresearch currently have 6 directors, including Om Dutt Tyagi, Tushar Srivastava Kumar, Kewal Kundanlal Handa and others.
